Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| Shin Nippon Biomedical Laboratories, Ltd., Medical Devices Deals, 2010 to YTD 2016 | 9 | 1 |
| Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
| Shin Nippon Biomedical Laboratories, Ltd., Pharmaceuticals &Healthcare, Deal Details | 12 | 21 |
| Venture Financing | 12 | 1 |
| WaVe Life Sciences Raises USD18 Million in Series A Financing | 12 | 1 |
| Partnerships | 13 | 1 |
| Shin Nippon Biomedical Labs Terminates Licensing Agreement with Besins Healthcare | 13 | 1 |
| SNBL USA Enters into Contract with BARDA | 14 | 1 |
| Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical | 15 | 1 |
| Pharmaceutical Product Development Forms Joint Venture with Shin Nippon Biomedical | 16 | 1 |
| ISA Therapeutics Enters into R&D Agreement with Shin Nippon Biomedical Labs | 17 | 1 |
| Shin Nippon Biomedical Labs Enters Into Research Agreement With Nagasaki University | 18 | 1 |
| Shin Nippon Biomedical Labs Enters Into Co-Development Agreement With Nihon University | 19 | 1 |
| Shin Nippon Biomedical Labs Enters Into Co-Development Agreement With Retina Institute Japan | 20 | 1 |
| Shin Nippon Biomedical Labs Enters Into Research Agreement With Riken | 21 | 1 |
| Shin Nippon Biomedical Labs To Enter Co-Development Agreement With Chiome Bioscience | 22 | 1 |
| Shin Nippon Biomedical Labs Enters Into Research Agreement With Nagasaki University For Cerebral Infarction Treatment | 23 | 2 |
| Shin Nippon Biomedical Labs Enters Into Research Agreement With Center For iPS Cells Research And Application | 25 | 1 |
| Licensing Agreements | 26 | 1 |
| Transcept Pharma And Shin Nippon Biomedical Labs Enter Into Licensing Agreement For Acute Migraine Treatment | 26 | 2 |
| Shin Nippon Biomedical Labs Enters Into Licensing Agreement With Pastorus Pharma | 28 | 1 |
| Equity Offering | 29 | 1 |
| Shin Nippon Biomedical Labs Raises USD0.1 Million in Private Placement of Shares upon Exercise of Warrants | 29 | 1 |
| Shin Nippon Biomedical Labs Completes Private Placement Of Shares For US$35.5 Million Upon Exercise Of Warrants | 30 | 1 |
| Shin Nippon Biomedical Labs Completes Private Placement Of Shares For US$38 Million Upon Exercise Of Warrants | 31 | 1 |
| Retina Institute Japan Announces Private Placement Of 300 Million Shares | 32 | 1 |
| Shin Nippon Biomedical Laboratories, Ltd. - Key Competitors | 33 | 1 |
| Key Employees | 34 | 1 |
| Locations And Subsidiaries | 35 | 2 |
| Head Office | 35 | 1 |
| Other Locations &Subsidiaries | 35 | 2 |
| Appendix | 37 | 1 |
| Methodology | 37 | 1 |
| About GlobalData | 37 | 1 |
| Contact Us | 37 | 1 |
| Disclaimer | 37 | 1 |